6.46Open5.47Pre Close602 Volume864 Open Interest72.00Strike Price358.93KTurnover4782.70%IV0.41%PremiumNov 29, 2024Expiry Date5.99Intrinsic Value100Multiplier-1DDays to Expiry0.32Extrinsic Value100Contract SizeAmericanOptions Type0.8680Delta0.0367Gamma13.45Leverage Ratio-695.9196Theta0.0000Rho11.67Eff Leverage0.0003Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet